UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | September 23, 2024 4:00 P.M. |
Form: | S-3 | ||||||
|
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | September 23, 2024 4:00 P.M. |
Form: | S-3 | ||||||
|
Date | Price Target | Rating | Analyst |
---|---|---|---|
8/9/2024 | $35.00 | Mkt Perform → Outperform | Barrington Research |
5/6/2024 | $50.00 | Hold → Buy | Lake Street |
2/23/2024 | $60.00 → $40.00 | Buy → Hold | Deutsche Bank |
2/23/2024 | $60.00 → $39.00 | Buy → Hold | Jefferies |
8/3/2022 | $145.00 | Overweight | Stephens |
2/28/2022 | $190.00 → $155.00 | Outperform | Barrington Research |
2/3/2022 | $180.00 → $150.00 | Buy | Deutsche Bank |
12/17/2021 | $180.00 | Buy | Deutsche Bank |
Lake Street analyst Brooks O'Neil upgrades ModivCare (NASDAQ:MODV) from Hold to Buy and maintains $50 price target.
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three and six months ended June 30, 2024. Second Quarter 2024 Summary: Service revenue of $698.3 million, remaining consistent with the second quarter of 2023 Net loss of $128.9 million or negative $9.07 per diluted common share Adjusted EBITDA(1) of $45.4 million, adjusted net loss(1) of $0.4 million and adjusted EPS(1) of negative $0.03 per diluted common share Cash used in operating activities during the quarter of $55.3 mil
Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the second quarter 2024 ended June 30, 2024, on Wednesday, August 7, 2024, after the market closes. Modivcare will host a conference call on Thursday, August 8, 2024, at 8:30 a.m. Eastern Time to discuss second quarter 2024 financial results. The conference call dial-in number for domestic callers is (888) 645-4404, and international callers should dial +1 (862) 298-0702. Interested parties may also a
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2024. First Quarter 2024 Summary: Service revenue of $684.5 million increased 3.3% from the first quarter of 2023 Net loss of $22.3 million or $1.57 per diluted common share Adjusted EBITDA(1) of $32.1 million, adjusted net loss(1) of $1.2 million and adjusted EPS(1) of negative $0.09 per diluted common share Cash provided by operating activities during the quarter of $9.6 million and free cash flow
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
ModivCare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that it has amended its Credit Agreement, dated February 3, 2022 (as amended to date, the "Credit Agreement"), with JPMorgan Chase Bank, N.A., as administrative agent, along with other key lenders. Key Amendment Highlights: Total Net Leverage Ratio Covenant: Increased for the quarter ended September 30, 2024, to 6.50x from 5.25x. Minimum Interest Coverage Ratio Covenant: Reduced for the quarter ended September 30, 2024, to 2.00x from 2.75x. This amendment ens
Modivcare Foundation, the philanthropic foundation of Modivcare (NASDAQ:MODV), is proud to highlight its support of Build Jake's Place, an organization dedicated to creating inclusive playgrounds for children and adults with disabilities. This contribution spotlights Modivcare's commitment to improving health outcomes and ensuring that everyone, regardless of ability, can engage in meaningful activities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240926105553/en/Modivcare and Build Jake's Place leaders gather to celebrate opening day of the Camden County NJ Miracle League (Photo: Business Wire) Build Jake's Place was founded
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today addressed its recent filings with the U.S. Securities and Exchange Commission ("SEC") and announced adjusted guidance. On September 12, 2024, the Company filed a Form S-3 shelf registration statement with the SEC, as well as a Form 8-K, providing additional information. Once declared effective by the SEC, the Form S-3 will provide the Company with flexibility to raise capital as needed over the next three years. The Company does not plan to issue equity at this time. The Compan
SC 13G - ModivCare Inc (0001220754) (Subject)
SC 13G/A - ModivCare Inc (0001220754) (Subject)
SC 13G/A - ModivCare Inc (0001220754) (Subject)
NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced the appointment of Jeff Bennett as Chief Strategy and Innovation Officer and Seth Ravine as Chief Commercial Officer, effective December 2023. "I am incredibly excited for the appointment of these two positions, underscoring our commitment to building a top-notch leadership team that will steer Modivcare's strategic course and drive success in this dynamic landscape," said Heath Sampson, President and CEO of Modivcare. "The addition of Jeff and Seth's roles reinfo
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Stacy Saal has stepped down from the Board of Directors in order to dedicate more time to her new professional endeavors. "We are grateful for Stacy's contributions to Modivcare and we wish her the best as she turns to her next chapter and pursues a number of exciting projects," said Chris Shackelton, Chairman of Modivcare's Board of Directors. "From her first day on the Board, Stacy was dedicated to driving value for shareholders. The experience, diligence,
Barrington Research upgraded ModivCare from Mkt Perform to Outperform and set a new price target of $35.00
Lake Street upgraded ModivCare from Hold to Buy and set a new price target of $50.00
Deutsche Bank downgraded ModivCare from Buy to Hold and set a new price target of $40.00 from $60.00 previously
8-K - ModivCare Inc (0001220754) (Filer)
EFFECT - ModivCare Inc (0001220754) (Filer)
8-K - ModivCare Inc (0001220754) (Filer)